Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Specific hemoperfusion through agarose acrobeads.

S Margel, L Marcus

    Applied Biochemistry and Biotechnology
    |February 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The world's largest omnivore is a fish.

    Ecology·2022
    Same author

    Designed proteinoid polymers and nanoparticles encapsulating risperidone for enhanced antipsychotic activity.

    Journal of nanobiotechnology·2020
    Same author

    Solidification of oil liquids by encapsulation within porous hollow silica microspheres of narrow size distribution for pharmaceutical and cosmetic applications.

    Materials science & engineering. C, Materials for biological applications·2019
    Same author

    Targeted drug delivery of near IR fluorescent doxorubicin-conjugated poly(ethylene glycol) bisphosphonate nanoparticles for diagnosis and therapy of primary and metastatic bone cancer in a mouse model.

    Journal of nanobiotechnology·2016
    Same author

    The relationship of aerobic capacity, anaerobic peak power and experience to performance in CrossFit exercise.

    Biology of sport·2015
    Same author

    Near IR fluorescent conjugated poly(ethylene glycol)bisphosphonate nanoparticles for in vivo bone targeting in a young mouse model.

    Journal of nanobiotechnology·2015

    New agarose acrobeads efficiently remove toxins and antibodies from blood during hemoperfusion. These biocompatible beads maintain blood cell and component integrity, offering a stable and effective extracorporeal blood purification method.

    Area of Science:

    • Biomaterials Science
    • Biomedical Engineering
    • Hemoperfusion Technology

    Background:

    • Microsphere technology is crucial for targeted substance removal.
    • Developing biocompatible materials for extracorporeal therapies is essential.
    • Acrobeads offer a high aldehyde-group content for ligand immobilization.

    Purpose of the Study:

    • To develop and evaluate crosslinked agarose acrobeads for hemoperfusion.
    • To assess the efficacy of agarose acrobeads in removing various substances from whole blood.
    • To determine the biocompatibility and stability of agarose acrobeads during hemoperfusion.

    Main Methods:

    • Encapsulation of polyacrolein microspheres (acrobeads) in a crosslinked agarose matrix.
    • Production of optimal spherical beads (0.5-0.8 mm) for hemoperfusion.

    Related Experiment Videos

  • Covalent binding of amino ligands (antibodies, antigens, etc.) to acrobeads under physiological pH.

    • Main Results:

    • Agarose acrobeads demonstrated stable structure and biocompatibility during in vitro and in vivo hemoperfusion.
    • Erythrocytes, leukocytes, thrombocytes, and soluble blood components remained unaltered.
    • Successful removal of specific antigens (digoxin, paraquat), antibodies, immune complexes, and metals (iron) was achieved.

    Conclusions:

    • Crosslinked agarose acrobeads are effective and safe for extracorporeal removal of unwanted substances from blood.
    • The high aldehyde content allows for versatile ligand immobilization, enabling targeted hemoperfusion.
    • Agarose acrobeads represent a promising biomaterial for advanced blood purification therapies.